Oklahoma Administrative Code › Title 310 - Oklahoma State Department of Health › Chapter 566 - Comprehensive Breast and Cervical Cancer Detection and Treatment › Subchapter 3 - Screening Service Provision › Section 310:566-3-1 - Service provision of the Oklahoma Comprehensive Breast and Cervical Cancer Early Detection Program

Current through Vol. 41, No. 20, July 1, 2024
The Oklahoma Comprehensive Breast and Cervical Cancer Early
				  Detection Program shall include the following key components:
(1) Program and Fiscal Management will be
				conducted by ensuring strategic planning, implementation, coordination,
				integration, and evaluation of all programmatic activities and administrative
				systems, as well as the development of key communication channels and oversight
				mechanisms to aid in these processes. Program Management will ensure that
				infrastructure adequately supports service delivery.
(2) Service Delivery directly provided or
				provided through contractual arrangements of specific and appropriate clinical
				procedures to detect breast and/or cervical abnormalities for women enrolled in
				the Oklahoma Breast and Cervical Cancer Early Detection Program. In the
				Oklahoma Breast and Cervical Cancer Early Detection Program appropriate
				clinical screening procedures include clinical breast examinations (CBE),
				mammograms, screening pelvic exams and pap tests. Appropriate clinical
				diagnostic procedures include diagnostic mammography, ultrasound of the breast,
				surgical consultation, biopsy of the cervical or breast, colopscopy of the
				cervix, and electrical loop excisional biopsies of the cervix. Women should
				receive patient education directed toward breast self-examination (BSE) and
				risk reduction.
(3) Referral,
				Tracking and Follow-up will be conducted utilizing a data system to monitor an
				enrolled woman's receipt of screening/re-screening, diagnostic, and treatment
				procedures. The enrolled woman will be notified of the results of the service
				delivery whether the results are normal, benign, or abnormal. The data system
				will provide tracking of appropriate and timely clinical services following an
				abnormal test result and/or diagnosis of cancer. Enrolled women with abnormal
				Pap smears or breast screening procedures will be provided comprehensive
				referral directing the woman to appropriate additional diagnostic or treatment
				services. The comprehensive referral will be written. Follow-up will be
				conducted to seek information about whether services were timely, completed, or
				met.
(4) Case Management will be
				provided and involve establishing, brokering, and sustaining a system of
				available clinical (screening, diagnostic, and treatment) and essential support
				services for all Oklahoma Breast and Cervical Cancer Early Detection Program
				enrolled women, and assisting clients diagnosed with cancer through the Program
				to obtain needed diagnostic and treatment services.
(5) Quality Assurance and Improvement will be
				conducted utilizing established standards, systems, policies and procedures to
				monitor, assess and identify practical methods for improvement of the program
				and its components. Quality assurance tools will include utilizing FDA and ACR
				minimum standards for mammography facilities and CLIA minimum standards for
				cytopathology and pathology laboratories. Quality assurance contributes to the
				identification of corrective actions to be taken to remedy problems found as a
				result of investigating quality of care.
(6) Professional Education will be provided
				through a variety of channels and activities that enable professionals to
				perform their jobs competently, identify needs and resources, and contribute to
				ensuring that health care delivery systems provide positive clinical
				outcomes.
(7) Population Based
				Public Education and Outreach will be provided that involves the systematic
				design and delivery of clear and consistent messages about breast and cervical
				cancer and the benefits of early detection, using a variety of methods and
				strategies to reach priority populations. Outreach activities should focus on
				women who have never been screened or rarely been screened and work toward the
				removal of barriers to care, i.e.: the need for childcare, respite care,
				interpreter services and transportation through collaborative activities with
				other community organizations.
(8)
				Coalitions and Partnerships will be developed to bring together groups and
				individuals who establish a reciprocal agreement for sharing resources and
				responsibilities to achieve the common goal of reducing breast and cervical
				cancer mortality.
(9) Surveillance
				will be conducted utilizing continuous, proactive, timely and systematic
				collection, analysis, interpretation and dissemination of breast and cervical
				cancer screening behaviors, incidence, prevalence, survival, and mortality of
				breast and/or cervical cancer. Epidemiological studies will be conducted
				utilizing Minimum Data Elements and other data sources to establish trends of
				disease, diagnosis, treatment, and research needs. Program planning,
				implementation, and evaluation shall be based on the epidemiological
				evidence.
(10) Evaluation will be
				conducted through systematic documentation of the operations and outcomes of a
				program, compared to a set of explicit or implicit standards or objectives. The
				Oklahoma Breast and Cervical Cancer Prevention and Treatment Advisory Committee
				shall review the service delivery contractual agreements as to their outcomes.
				The Oklahoma Breast and Cervical Cancer Prevention and Treatment Advisory
				Committee shall make recommendations based on the evaluation in its annual
				report.
Added at 22 Ok Reg 400,
				  eff 12-21-04 (emergency); Added at 22 Ok Reg 2409, eff
				  7-11-05